Molecular Forms of Prostate-Specific Antigen in Women with Breast Diseases
Author Information
Author(s): GH Borchert, DN Melegos, G Tomlinson, M Giai, R Roagna, R Ponzone, L Sgro, EP Diamandis
Primary Institution: Mount Sinai Hospital, Toronto, Ontario, Canada
Hypothesis
Can the molecular forms of serum PSA be used for diagnosing breast diseases including breast cancer?
Conclusion
About half of the patients with breast cancer or benign breast diseases have free PSA as the major molecular form in their serum.
Supporting Evidence
- Breast cancer patients have presurgical serum total PSA levels similar to those of blood donors.
- Total serum PSA concentration decreases with age in women with idiopathic hirsutism, cancer patients, and patients with benign breast diseases.
- The major molecular form of PSA in normal and hirsute women is PSA bound to a1-antichymotrypsin.
- 44% of presurgical cancer patient sera have free PSA as the major molecular form.
- 58% of benign breast disease patients also have free PSA as the major molecular form.
Takeaway
This study looked at a special protein called PSA in women's blood to see if it can help tell if they have breast problems. They found that many women with breast issues have a different type of PSA in their blood compared to healthy women.
Methodology
The study used a highly sensitive immunofluorometric procedure to measure total PSA concentration and high-performance liquid chromatography (HPLC) to separate PSA forms.
Limitations
The study was limited to sera with total PSA > 15 ng/ml for HPLC analysis, reducing the sample size for fractionation.
Participant Demographics
Participants included female blood donors, women with idiopathic hirsutism, breast cancer, and benign breast diseases.
Statistical Information
P-Value
0.0006
Confidence Interval
95% CI: 0.7-4.5 ng/ml for free PSA
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website